Back

Lipoprotein(a) levels above 70 mg/dL are an independent predictor for long-term major adverse cardiovascular events in patients with premature (<40 years) acute coronary syndrome

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Loukianos Rallidis

Attikon University Hospital, Athens (Greece)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Swieszkowski (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Doctor J. Costabel (Buenos Aires, AR)
Abstract
Presentation thumbnail
Doctor H. Wada (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of lipoprotein A on long-term outcomes in acute coronary syndrome: a retrospective cohort analysis
thumbnail
Congress Presentation
Prognostic values of lipoprotein(a) levels for secondary prevention of acute coronary syndrome among patients who underwent primary percutaneous coronary intervention
thumbnail
Congress Presentation
Prevalence of elevated lipoprotein(a) in premature ASCVD patients and its association with major adverse cardiovascular events: analysis of a large US electronic health record database

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources